Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 19 studies | 43% ± 14% | |
| lung | 18 studies | 49% ± 18% | |
| intestine | 11 studies | 41% ± 20% | |
| brain | 11 studies | 30% ± 13% | |
| kidney | 9 studies | 44% ± 15% | |
| eye | 7 studies | 29% ± 13% | |
| liver | 6 studies | 40% ± 24% | |
| pancreas | 5 studies | 59% ± 26% | |
| placenta | 5 studies | 33% ± 17% | |
| bone marrow | 5 studies | 34% ± 14% | |
| uterus | 5 studies | 48% ± 22% | |
| lymph node | 5 studies | 50% ± 12% | |
| skin | 4 studies | 32% ± 15% | |
| prostate | 4 studies | 36% ± 13% | |
| breast | 4 studies | 50% ± 9% | |
| adrenal gland | 3 studies | 32% ± 7% | |
| esophagus | 3 studies | 53% ± 30% | |
| thymus | 3 studies | 59% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 8946.31 | 1445 / 1445 | 100% | 195.66 | 183 / 183 |
| lung | 100% | 7417.96 | 578 / 578 | 100% | 332.73 | 1155 / 1155 |
| ovary | 100% | 7527.84 | 180 / 180 | 100% | 457.38 | 430 / 430 |
| prostate | 100% | 7722.53 | 245 / 245 | 100% | 513.70 | 502 / 502 |
| stomach | 100% | 6476.81 | 359 / 359 | 100% | 286.16 | 286 / 286 |
| thymus | 100% | 7595.48 | 653 / 653 | 100% | 532.68 | 604 / 605 |
| breast | 100% | 8820.62 | 459 / 459 | 100% | 537.45 | 1116 / 1118 |
| brain | 100% | 5957.63 | 2637 / 2642 | 100% | 464.42 | 705 / 705 |
| bladder | 100% | 9415.76 | 21 / 21 | 100% | 487.71 | 503 / 504 |
| skin | 100% | 8082.67 | 1809 / 1809 | 100% | 419.37 | 471 / 472 |
| uterus | 100% | 8146.55 | 170 / 170 | 100% | 444.23 | 458 / 459 |
| pancreas | 100% | 3461.60 | 327 / 328 | 100% | 409.47 | 178 / 178 |
| kidney | 100% | 8226.58 | 89 / 89 | 100% | 300.59 | 898 / 901 |
| intestine | 100% | 8237.42 | 966 / 966 | 100% | 323.78 | 525 / 527 |
| liver | 100% | 3194.34 | 225 / 226 | 100% | 245.68 | 406 / 406 |
| adrenal gland | 100% | 6118.34 | 258 / 258 | 99% | 314.07 | 227 / 230 |
| adipose | 100% | 8550.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 10233.08 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 338.18 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 634.17 | 29 / 29 |
| spleen | 100% | 6905.52 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 391.75 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 432.17 | 1 / 1 |
| muscle | 100% | 5418.90 | 799 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 5108.46 | 855 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 5807.36 | 921 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048870 | Biological process | cell motility |
| GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_0008064 | Biological process | regulation of actin polymerization or depolymerization |
| GO_0010592 | Biological process | positive regulation of lamellipodium assembly |
| GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
| GO_0048144 | Biological process | fibroblast proliferation |
| GO_0016601 | Biological process | Rac protein signal transduction |
| GO_0007015 | Biological process | actin filament organization |
| GO_2000601 | Biological process | positive regulation of Arp2/3 complex-mediated actin nucleation |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0030027 | Cellular component | lamellipodium |
| GO_0031209 | Cellular component | SCAR complex |
| GO_0044877 | Molecular function | protein-containing complex binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0031267 | Molecular function | small GTPase binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | BRK1 |
| Protein name | Protein BRICK1 (BRK1) |
| Synonyms | HSPC300 C3orf10 MDS027 |
| Description | FUNCTION: Involved in regulation of actin and microtubule organization. Part of a WAVE complex that activates the Arp2/3 complex. As component of the WAVE1 complex, required for BDNF-NTRK2 endocytic trafficking and signaling from early endosomes (By similarity). . |
| Accessions | ENST00000530758.2 [Q8WUW1-1] Q8WUW1 |